Compare SHOP & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHOP | TMO |
|---|---|---|
| Founded | 2004 | 1956 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 222.4B | 216.4B |
| IPO Year | 2015 | N/A |
| Metric | SHOP | TMO |
|---|---|---|
| Price | $111.33 | $545.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 32 | 19 |
| Target Price | $167.48 | ★ $639.83 |
| AVG Volume (30 Days) | ★ 11.3M | 2.7M |
| Earning Date | 02-11-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 0.32% |
| EPS Growth | ★ 28.16 | 7.32 |
| EPS | 1.36 | ★ 17.74 |
| Revenue | $10,696,000,000.00 | ★ $44,556,000,000.00 |
| Revenue This Year | $31.82 | $6.10 |
| Revenue Next Year | $23.96 | $5.26 |
| P/E Ratio | $82.67 | ★ $30.60 |
| Revenue Growth | ★ 30.25 | 3.91 |
| 52 Week Low | $69.84 | $385.46 |
| 52 Week High | $182.19 | $643.99 |
| Indicator | SHOP | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 23.32 | 28.13 |
| Support Level | $108.79 | $541.34 |
| Resistance Level | $144.14 | $588.85 |
| Average True Range (ATR) | 6.46 | 14.68 |
| MACD | -3.11 | -10.06 |
| Stochastic Oscillator | 8.87 | 0.72 |
Shopify offers an e-commerce platform primarily to small and medium-size businesses. The firm has two segments. The subscription solutions segment allows Shopify merchants to conduct e-commerce on a variety of platforms, including the company's website, physical stores, pop-up stores, kiosks, social networks (Facebook), and Amazon. The merchant solutions segment offers add-on products for the platform that facilitate e-commerce and include Shopify Payments, Shopify Shipping, and Shopify Capital.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).